David M. Spencer, Chief Scientific Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 7,967 shares at $17.17 ($139K) on 2016-12-01, disclosed to the SEC on 2016-12-05.
Open-market sale of $139k BLCM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.17 | 2,967 | $51K | 36.8% |
| 2 | $17.17 | 2,967 | $51K | 36.8% |
| 3 | $18.04 | 2,033 | $37K | 26.5% |
| Total | $17.39 avg | 7,967 | $139K | 100% |
| Filing → |
| BLCM | SELL | 2017-07-12 | $231K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $100K | — | Filing → |
| BLCM | SELL | 2016-09-23 | $453K | — | Filing → |